PDS Biotechnology Corporation PDSB
0.89 USD -0.03 (-3.28%)
Regular-session close
0.95 +0.06 +6.29%
Pre-market · Nov 18, 6:13 AM ET
0.8883 Day range 0.98
0.195 52-week range 1.79
- YTD
- +16.08%
- 1 year
- +13.28%
News
benzinga.com PDS Biotechnology Q3 EPS $(0.11) Misses $(0.09) Estimate PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 42.11 percent increase over losses of…
globenewswire.com PDS Biotech Reports Third Quarter 2026 Financial Results PRINCETON, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company focused on transforming how…benzinga.com B. Riley Securities Reiterates Buy on PDS Biotechnology, Raises Price Target to $4 B. Riley Securities analyst Mayank Mamtani reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and raises the price target from $3 to $4.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) shares rose 23.1% to $89.86 during Tuesday's regular session. The market value of their outstanding shares is at $5.6 billion. As per the press release,…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pomdoctor (NASDAQ:POM) stock moved upwards by 115.1% to $1.43 during Wednesday's regular session. The market value of their outstanding shares is at $4.9 million. Stablecoin Development…
